Country Report / New Puerto Rico Pharma Report January 2020 Out Now
Puerto Rico had to rebuild itself – in many cases quite literally – after the devastation wrought by Hurricane Maria in 2017. However, despite the havoc that Maria brought to…
Czech Drug Shortages / Both Local & International Solutions Needed
Medicine shortages are a European-wide issue. In 2016, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) formed a task force to investigate availability issues, including medicines that are…
AMR / France: Becoming a European Vaccination Leader?
France is home to the highest rates of vaccine mistrust in Europe, with a third of French people disagreeing that vaccines are safe, according to the Wellcome Global Monitor survey.…
2020 Trends / A More Measured Tone at the J.P. Morgan Healthcare Conference
David Crean summarises the mood at the recent J.P. Morgan Healthcare Conference 2020 in San Francisco, noting a more subdued atmosphere than previous years, with reduced attendances and no big…
Canada / Global Pharma has Reinvented R&D: Will Canadian Start-Ups Lead the Next Phase?
John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the forefront of the next wave of global biopharmaceutical R&D. BlueRock Therapeutics, a promising…
Biosimilar Uptake in Europe / Big Challenges; Bigger Rewards
Isabell Remus, chair of the Biosimilar Medicines Group at Medicines for Europe outlines the issues that need to be addressed to keep driving biosimilar uptake in Europe. Since the…
MEA / UAE to Boost Health Research Capabilities as Part of 50-Year Strategy
The United Arab Emirates’ Cabinet, the de facto executive branch of the federation, recently announced a set of decisions and legislation to support health research as a pillar of the…
Vaccines / Back to Vax in Romania
As anti-vaccination sentiments resurface globally, so have once-eradicated diseases. This situation is especially prevalent in Romania and has become a severe economic, social, and health threat. Romania’s Struggle with…
LATAM / Mexico: Despite Hurdles, Pharma Market Remains Attractive
The United States Trade Representative Office has been engaging with a number of countries, including Mexico, to address concerns related to IP protection and enforcement and market access barriers for…
AMR / The Fight Against Superbugs: Properly Incentivising Antimicrobial R&D Is Key
BIO’s Greg Frank outlines the alarming growth of drug-resistant infections and the steps that need to be taken to combat this rapidly emerging global health threat. Drug-resistant superbugs are…
Hot Topics / Chinese Biotech
PharmaBoardroom sat down with more than 25 biotech CEOs in China in 2019. We analyzed the contents of the interviews and found the following recurring themes at the top of…
Life Sciences’ Growing Demand for AI Assets
Digital health deal values in biopharma jumped to USD 6.4 billion in 2019, largely thanks to software company Dassault Systemes Americas Corp.’s USD 5.9 billion acquisition of health tech company…